Want to see IN:DIVISLAB full AI Analyst Report?

Divi's Laboratories Limited (DIVISLAB) Price & Analysis

8 Followers

DIVISLAB Stock Chart & Stats

₹8680.00

₹165.50(2.28%)

At close: Jul 27 4:00 PM EDT

₹8680.00

₹165.50(2.28%)

Day’s Range― - ―

52-Week Range₹5,637.50 - ₹10,000.00

Previous CloseN/A

Volume544.67K

Average Volume (3M)32.22K

Market Cap

₹2.48T

Enterprise Value₹1.54M

Total Cash (Recent Filing)₹32.33B

Total Debt (Recent Filing)₹0.00

Price to Earnings (P/E)85.1

Beta0.74

Next Earnings

Nov 09, 2026

EPS Estimate

30.1

Next Dividend Ex-DateN/A

Dividend Yield0.32%

Share Statistics

EPS (TTM)110.22

Shares Outstanding265,468,570

10 Day Avg. Volume28,408

30 Day Avg. Volume32,219

Financial Highlights & Ratios

PEG Ratio3.57

Price to Book (P/B)9.42

Price to Sales (P/S)14.95

P/FCF Ratio317.60

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

₹9,100.00

Price Target Upside4.84% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering1

EPS Forecast (FY)124.74

Revenue Forecast (FY)₹125.94B

Bulls Say, Bears Say

Bulls Say

Conservative Balance SheetNegligible leverage and a steadily expanding equity base give Divi’s Laboratories substantial financial resilience. This supports continued investment, reduces dependence on external funding, and provides flexibility to manage cyclical demand or regulatory setbacks over the next several quarters.

Improving Operating Cash FlowThe strong recent rise in operating cash flow indicates that the core business is converting activity into meaningful internal funding. Greater cash generation can support capacity investment, working-capital needs, and strategic execution without materially increasing financial leverage.

Revenue And Earnings RecoveryThe rebound in revenue and absolute earnings demonstrates renewed operating scale after the weaker period in 2024–2025. Divi’s exposure to APIs and custom synthesis gives the company an established platform from which sustained customer demand can support further earnings growth.

Bears Say

Margin NormalizationProfitability remains strong, but the decline from the 2022 net-margin peak shows that earlier earnings economics have not been fully sustained. Continued normalization could limit earnings growth even if revenue expands, reducing operating leverage and the durability of prior returns.

Uneven Free Cash FlowFree cash flow has been materially less consistent than operating cash flow, with sharp variation across recent years. This suggests that reinvestment, capital spending, or working-capital movements can absorb operating cash, making internally funded expansion and cash conversion less predictable.

Moderating Revenue GrowthThe longer-term revenue recovery is positive, but the near-flat 2025 result and only moderate 2026 growth indicate that expansion has not been consistently strong. A slower top-line trajectory could constrain fixed-cost absorption and make earnings increasingly dependent on margins or product mix.

Divi's Laboratories Limited News

Divi’s Laboratories Posts Q1 FY27 Earnings Call Transcript for Investors

Divi’s Laboratories Limited ( ($IN:DIVISLAB) ) has shared an update. Divi’s Laboratories Limited has released the transcript of...

1M ago

Divi’s Laboratories to Close Trading Window Ahead of Q1 FY27 Results

The latest announcement is out from Divi’s Laboratories Limited ( ($IN:DIVISLAB) ). Divi’s Laboratories Limited has announced the...

3M ago

Divi’s Labs Posts FY26 Q4 Earnings Call Audio for Investors

An update from Divi’s Laboratories Limited ( ($IN:DIVISLAB) ) is now available. Divi’s Laboratories Limited has announced that...

4M ago

Divi’s Laboratories Opens Special Window for Transfer and Demat of Physical Shares

Divi’s Laboratories Limited ( ($IN:DIVISLAB) ) just unveiled an announcement. Divi’s Laboratories has announced the publication of newspaper...

6M ago

Divi’s Laboratories Files SEBI Dematerialisation Compliance Certificate for December Quarter

An update from Divi’s Laboratories Limited ( ($IN:DIVISLAB) ) is now available. Divi’s Laboratories Limited has submitted to...

9M ago

Divi’s Laboratories to Close Trading Window Ahead of Q3 FY26 Results

Divi’s Laboratories Limited ( ($IN:DIVISLAB) ) has shared an announcement. Divi’s Laboratories Limited has announced that it will...

9M ago

Divi’s Laboratories Releases Unaudited Financial Results for September 2025

Divi’s Laboratories Limited ( ($IN:DIVISLAB) ) just unveiled an announcement. Divi’s Laboratories Limited announced the publication of its...

11M ago

Divi’s Laboratories Announces Trading Window Closure

Divi’s Laboratories Limited ( ($IN:DIVISLAB) ) just unveiled an announcement. Divi’s Laboratories Limited has announced the closure of...

12M ago

Divi’s Laboratories Releases Q1 FY2026 Earnings Call Transcript

Divi’s Laboratories Limited ( ($IN:DIVISLAB) ) has provided an announcement. Divi’s Laboratories Limited has released the transcript of...

1y ago

Divi’s Laboratories Reports Stable Q1 Financial Results for 2025

Divi’s Laboratories Limited ( ($IN:DIVISLAB) ) has shared an announcement. Divi’s Laboratories Limited has announced its unaudited financial...

1y ago

DIVISLAB FAQ

What was Divi's Laboratories Limited’s price range in the past 12 months?

Divi's Laboratories Limited lowest stock price was ₹5637.50 and its highest was ₹10000.00 in the past 12 months.

What is Divi's Laboratories Limited’s market cap?

Divi's Laboratories Limited’s market cap is ₹2.48T.

When is Divi's Laboratories Limited’s upcoming earnings report date?

Divi's Laboratories Limited’s upcoming earnings report date is Nov 09, 2026 which is in 51 days.

How were Divi's Laboratories Limited’s earnings last quarter?

Divi's Laboratories Limited released its earnings results on Aug 01, 2026. The company reported ₹33.95 earnings per share for the quarter, beating the consensus estimate of ₹25.392 by ₹8.558.

Is Divi's Laboratories Limited overvalued?

According to Wall Street analysts Divi's Laboratories Limited’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Divi's Laboratories Limited pay dividends?

Divi's Laboratories Limited pays a Annually dividend of ₹30 which represents an annual dividend yield of 0.32%. See more information on Divi's Laboratories Limited dividends here

What is Divi's Laboratories Limited’s EPS estimate?

Divi's Laboratories Limited’s EPS estimate is 30.1.

How many shares outstanding does Divi's Laboratories Limited have?

Divi's Laboratories Limited has 265,468,570 shares outstanding.

What happened to Divi's Laboratories Limited’s price movement after its last earnings report?

Divi's Laboratories Limited reported an EPS of ₹33.95 in its last earnings report, beating expectations of ₹25.392. Following the earnings report the stock price went up 4.889%.

Which hedge fund is a major shareholder of Divi's Laboratories Limited?

Currently, no hedge funds are holding shares in IN:DIVISLAB

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Divi's Laboratories Limited

Divi's Laboratories Limited, established in 1990 and based in Hyderabad, India, operates globally in the production and distribution of generic active pharmaceutical ingredients (APIs), intermediate chemicals, and nutraceuticals. The company's market footprint encompasses India, the United States, Asia, Europe, and other international regions. In addition to its core product lines, Divi's offers bespoke synthesis services for APIs and intermediates. It also provides a diverse range of carotenoids and markets various vitamins, catering to the nutritional, pharmaceutical, food and beverage, and animal feed industries. The firm was formerly known as Divi's Research Center before rebranding to Divi's Laboratories Limited in 1994.

Divi's Laboratories Limited (DIVISLAB) Earnings & Revenues

Historic Earnings Reports

DIVISLAB Stock 12 Month Forecast

Average Price Target

₹9,100.00

▲(4.84% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"5686":"₹5,686","6556":"₹6,556","7426":"₹7,426","8296":"₹8,296","9166":"₹9,166"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":9100,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">₹9K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":9100,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">₹9K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":9100,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">₹9K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[5686,6556,7426,8296,9166],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2025","6":"Mar<br/>2026","9":"Jun<br/>2026","12":"Sep<br/>2026","25":"Sep<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,9165,9160,9155,9150,9145,9140,9135,9130,9125,9120,9115,9110,9105,{"y":9100,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,9165,9160,9155,9150,9145,9140,9135,9130,9125,9120,9115,9110,9105,{"y":9100,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,9165,9160,9155,9150,9145,9140,9135,9130,9125,9120,9115,9110,9105,{"y":9100,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":6066.027,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5687.239,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6718.436,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6395.817,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6316.544,"date":1767225600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":5935.814,"date":1769904000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":6377.044,"date":1772323200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":5882.683,"date":1775001600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":6478.625,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6524.884,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6515.672,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8056.65,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9165,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >